PP
VYNT

PDT Partners’s Vyant Bio, Inc. Common Stock VYNT Stock Holding History

PDT Partners’s Portfolio VYNT Stock Details VYNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-177
Closed -$301K – 1655
2014
Q2 		$301K Buy
+177
New +$337K 0.01% 1195

Other funds holding VYNT

Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
CM
Castleark Management Chicago, Illinois $3.71B AUM 65.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NC
Northpointe Capital Bloomfield Hills, Michigan $258M AUM 1.97% 1-Year Est. Return
GMCM
Gruber & McBaine Capital Management San Francisco, California $369M AUM 12.23% 1-Year Est. Return
SIM
SSI Investment Management Los Angeles, California $1.72B AUM 7.09% 1-Year Est. Return
SCM
Sterneck Capital Management Kansas City, Missouri $233M AUM 21.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DM
Diker Management New York $130M AUM 97.77% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

PDT Partners's VYNT Position: Q3 2014 in Review

PDT Partners sold out of Vyant Bio, Inc. Common Stock (VYNT) in Q3 2014, closing a stake of 177 shares — an estimated $301K sold.

PDT Partners first reported a position in VYNT in Q2 2014 and held it in 1 quarter. The position peaked at $301K in Q2 2014. 28 funds tracked by Wall St. Rank hold VYNT as of Q3 2014.

  • PDT Partners reported no remaining Vyant Bio, Inc. Common Stock position as of Q3 2014 after selling out during the quarter.
  • PDT Partners sold 177 Vyant Bio, Inc. Common Stock shares in Q3 2014, an estimated $301K.
  • PDT Partners first reported a position in Vyant Bio, Inc. Common Stock in Q2 2014 and held it in 1 quarter.
  • PDT Partners's Vyant Bio, Inc. Common Stock position peaked at $301K in Q2 2014.
  • 28 funds tracked by Wall St. Rank held Vyant Bio, Inc. Common Stock as of Q3 2014.

Based on PDT Partners's 13F filing for Q3 2014, filed 14 Nov 2014.